Panacea Biotec is planning to raise Rs 250 crore by way of issue of equity shares and/or other securities. In this regards, the company is conducting Postal Ballot for obtaining approval of members for passing special resolution.
The Notice is being dispatched to the shareholders of the Company whose names appear in the Register of Members of the Company as on the cut-off date i.e. September 15, 2017 and the same is being sent to the members of the company through e-mail / post.
The company has also provided remote e-voting facility to the members to vote electronically through e-voting platform provided by NSDL.
Panacea Biotec is a leading biotechnology company with established research, manufacturing and marketing capabilities. It is one of the largest vaccine producers and leading Biotechnology Companies in India.
